We are exploring cell autonomous (genetics, epigenetics, and proteomics) mechanisms of breast cancer metastasis and resistance to therapy.
For these studies, we use unbiased genomics, proteomics, single cell analysis, CRISPR, shRNA, and transposon-based screens, and mathematical modeling.
